Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 19 kDa (CEP19) is a small, 167-amino acid protein that localizes to the distal end of the mother centriole within the centrosome and is critical for the initiation of primary cilia formation (ciliogenesis)[1][2]. CEP19 interacts with other centrosomal proteins—FOP (FGFR1OP) and CEP350—forming a regulatory module that is necessary for docking ciliary vesicles to centrioles and for early steps in cilium assembly[1][2]. Disruption of CEP19 function, including by a truncating R82* mutation, results in defective ciliogenesis and is associated with morbid obesity, indicating its likely involvement in ciliopathies[1][2]. There are no established roles for CEP19 as a direct target of drugs or as a biomarker in clinical applications at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 19 kDa (CEP19).